Chelsea Therapeutics International (CHTP)
News
| May 25 | @HighRiskBuyer @Lucasm82 $CHTP no date given but results out soon CH-1450 probably this coming week! Either good or bad! We shall see!!! by BiopharmaPro |
| May 25 | RT @Lucasm82 $CHTP Anyone know when we could hear results next week on phase II CH-4051?no date given. u'll know when this opens big or bad. by HighRiskBuyer |
| May 25 | $CHTP Anyone know when we could hear results next week on phase II CH-4051? by Lucasm82 |
| May 25 | $CHTP pump more. by HighRiskBuyer |
| May 24 | $CHTP $CLSN $AMRN $HZNP -showing great potential amidst market $SPY jitters, added $AAPL $OVTI $AG today $$ by peterumble |
| May 24 | RT @tweetingstocks $CHTP HOD working its way no position in either at the moment. On my watchlist __ People waiting for CH-4051 news, binary by Glopolon |
| May 24 | $CHTP HOD and $ARNA working its way no position in either at the moment. On my watchlist by tweetingstocks |
| May 24 | Shorter Timeframe, More Risky Fool |
| May 24 | $CHTP peeps proving me wrong so far. I thought this dropped more before any move up. Good for you. by tweetingstocks |
| May 24 | $CHTP needs volume... by HighRiskBuyer |
| May 22 | BlackRock, HollyFrontier Among Stocks Down on High Volume Tuesday Fox Business |
| May 22 | Chelsea Therapeutics (CHTP) Completes End-of-Review Meeting with FDA Over Northera ND... |
| May 16 | 5 Biotechnology Stocks With Upcoming Catalysts |
| May 11 | Upcoming Deadline: The Law Firm of Levi & Korsinsky Notifies Investors With Losses on... |
Profile
Exchange: NASDAQCM Sector: Healthcare Industry: Biotechnology
1 Year Total Return Performance
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Chelsea Therapeutics International is down 57.50% over the last year vs S&P 500 Total Return up 1.18%, Incyte Corporation up 25.06%, and Shire down 4.59%.
- CHTP Total Returns
- ^SPXTR Total Returns
- INCY Total Returns
- SHPGY Total Returns
Fundamentals
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Cash Flow Statement View Statement
You may also be interested in these CHTP related companies
Pro Strategies Featuring CHTP
Did Chelsea Therapeutics International make it into our Pro Portfolio Strategies?
CHTP Charts
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Other CHTP Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership MSN Money
- SEC Filings SEC
- Technical Charts Chart.ly
- Trading Ideas Benzinga
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| CHTP | 1.87 | -0.03 | -1.58% | 125.36M |
| CHT | 30.48 | -0.14 | -0.46% | 23.64B |
| CHSP | 17.78 | +0.17 | +0.97% | 571.27M |
| CHSI | 87.63 | +1.29 | +1.49% | 4.403B |
| CHS | 15.16 | +0.06 | +0.40% | 2.539B |
| CHRW | 59.69 | -0.13 | -0.22% | 9.731B |
| CHRS | 7.33 | +0.00 | +0.00% | 854.16M |
| CHRM | 7.28 | +0.08 | +1.11% | 283.77M |
| CHOP | 2.61 | -0.04 | -1.51% | 155.11M |
| CHNR | 6.875 | +0.41 | +6.26% | 171.26M |
